Empowering Functional VPs: Strategic Guidance for Sustainable Cold Chain Success
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsThe global regulatory experts at Modality Solutions provide a detailed, tactical approach for meeting the new requirements for container closure integrity (CCI) of sterile pharmaceutical products detailed in the revised Annex 1 EU GMP.
Download the slide deck created by industry experts, Andrew Larrigan and Carson Dickey to understand how the changes to EU Annex 1 will impact your cold chain strategy for container closure integrity.
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsAre you aware of the open data files published online by the FDA? This...
read Details10 Common Misconceptions of Cold Chain Validation, as Explained by AI, commentary by Gary...
read Details